Products Approved 2013-2018
Approved in the U.S. Approved outside the U.S.
Roche
Approved in the U.S. / Approved outsize the U.S.
Roche
For Adults in US, EU, and OUS, Pediatric Indication approved in EU, OUS
Takeda
Roche
Roche
Takeda
Products Approved in 2020
Approved for MM in US, EU, Japan, OUS, Approved for AL amyloidosis in US, EU, Japan, China
Janssen
Approved in the US & EU
Roche
Janssen
Roche
Potential approval target 2023-2025
argenx
Roche
Roche
Bristol Myers Squibb
Bristol Myers Squibb
argenx
argenx
argenx
argenx
argenx
argenx
Roche
Roche
Bristol Myers Squibb
Bristol Myers Squibb
argenx
argenx
argenx
argenx
argenx
Potential approval target 2025-2027
Janssen
Bristol Myers Squibb
argenx
Caprisa
Horizon
RILPIVIRINE
Undisclosed
Takeda
ViiV Healthcare
ViiV Healthcare
CHUGAI
Janssen
Bristol Myers Squibb
Argenx
Capirsa
Horizon
Janssen
Roche
Takeda
ViiV Healthcare
ViiV Healthcare
CHUGAI
